Collaborative initiative of biomedical researchers at Northwestern, UChicago and UIC. Generously funded by the Searle Funds at The Chicago Community Trust.
The CSB is excited to announce two new DREAM positions: Project Manager Lead and Project Coordinator. Interested in accelerating the engineering of proteins for a range of important biotechnology applications? Apply here: bit.ly/4hmlwwH
The 2nd Chicago BioEngineering Conference (CBEC) is back — Sept. 17–18 in downtown Chicago! 🧬
Omics. Bioelectronics. AI × bio. A stellar speaker lineup. Two days of science that matters.
Space is limited → register now: bit.ly/4vqlXLj
This is what BioCentury Inc's Grand Rounds is all about. Facilitating cross-regional alignment on how to address the crisis facing early-stage innovation. It reflects the urgency of the moment and the recognition that the solution requires collective will, not just local effort.
Professor @ShanaOKelley and @Biohub teams released an AI “world model” of protein biology—one that learns how proteins work, then predicts and designs new ones.
spr.ly/6016B8UsnE
ALT Professor Shana Kelley and Biohub teams released an AI \u201Cworld model\u201D of protein biology\u2014one that learns how proteins work, then predicts and designs new ones.
CBC's @mihoffmann opening up the @BioCentury#GrandRoundsUS conference by sharing insights on the value of early-stage innovators mapping out development strategy, investor positioning, and commercial viability alongside the TTP blueprint to make their science investible.
Today is the day! We’re so proud to see CBC EF Mandy Pinheiro take the stage at #Science2Startup 2026 with Evina Biosciences!
We’re excited for the conversations ahead and proud to represent the incredible #Midwest biotech ecosystem that’s helping build what’s next.
The energy at CBX’s “Next Gen Protein Design: AI, Quantum + Beyond” says it all—this is a real inflection point.
AI + computational advances are expanding what’s possible in biology. Quantum is starting to push those boundaries even further
But the real edge in Chicago + the Midwest? Density.
Researchers. Operators. Clinicians. Investors. All working across disciplines to connect these capabilities with intention.
The future of biotech isn’t one breakthrough—it’s how we integrate + translate them into impact.
Congrats to Evina Biosciences on being selected to the 2026 Science2Startup cohort!
Moving from target validation to lead ID with CBC support, Evina is developing a first-in-class, oral therapeutic for uterine fibroids.
bit.ly/4m5zJPA
Last call for Pitch & Poster Proposals for possible inclusion in the 2026 Critical Care Innovation Incubator that will be held on March 21, in Chicago in conjunction with the 2026 Critical Care Congress. Submission Deadline: January 30 at 11:59pm (CT). bit.ly/CCIIproposals
Exciting work from CBC award recipient, @GRocklin, and his lab. Led by Cydney Martell, the Rocklin Lab is establishing the design rules for miniprotein stability and aggregation potential.
This approach is a great example of how thinking ahead can directly strengthen how academic discoveries can expediently enter the translational pipeline.
Are you a researcher with a biotech innovation that needs funding to move closer to commercialization? The CBC Accelerator Award provides up to $250K to help you bridge the gap from discovery to impact.
For more info 👇
🔗 chicagobiomedicalconsortium.…
📅 Deadline: July 1, 2025
In a recent episode of the Science in Translation podcast (@NUCATSInstitute), Priya Kumthekar, MD, discusses her efforts to bring scientific advances to her patients with brain tumors by collaborating with small companies and how she is working with @ChiBiomed to streamline the commercialization process. Listen now: nucats.northwestern.edu/abou…
#QuantumComputing could one day crack the toughest problems in drug discovery, but the tech is still early.
#GrandRoundsUS25 explores how @intersect_IL, @psiquantum, @uchicago, and others are thinking ahead to help biomedicine prepare for the quantum future.